Similar Papers

Paper Title
Journal
Date
Author
Natural history of hepatitis C virus infection in a large national seroconversion cohort in the direct-acting antiviral agent era: Results from ERCHIVES.
Adeel A Butt ... Peng Yan
Journal of viral hepatitis | VOL. 28
Adeel A Butt, et. al.Adeel A Butt ... Peng Yan
28 Mar 2021
Hepatitis C virus care cascade in persons experiencing homelessness in the United States in the era of direct-acting antiviral agents: A scoping review.
Aubrey Del Rosario ... Sara Doorley
Journal of Viral Hepatitis | VOL. 28
Aubrey Del Rosario, et. al.Aubrey Del Rosario ... Sara Doorley
11 Aug 2021
Abstract 12659: Improved Heart Transplant Outcomes Among Patients With Hepatitis C Virus Infection in the Era of Direct-acting Antiviral Agents
Tomohiro Fujisaki ... Shinobu Itagaki
Circulation | VOL. 142
Tomohiro Fujisaki, et. al.Tomohiro Fujisaki ... Shinobu Itagaki
17 Nov 2020
Current status of treatment of chronic hepatitis C and related challenges in the "Pre-DAA Era" in China
...
Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology | VOL. 24
, et. al. ...
20 Nov 2016
View more papers

More From: Journal of Hepatology

Paper Title
Journal
Date
Author
Introducing the Breakthrough Beyond the Journal series.
Vlad Ratziu
Journal of hepatology | VOL. 82
Vlad RatziuVlad Ratziu
01 Feb 2025
Number of people treated for hepatitis C virus infection in 2014-2023 and applicable lessons for new HBV and HDV therapies
Homie A Razavi ... Eli Zuckerman
Journal of Hepatology | VOL. -
Homie A Razavi, et. al.Homie A Razavi ... Eli Zuckerman
01 Feb 2025
MICROB-PREDICT works on identifying microbiome-based predictors and mechanisms of decompensated liver cirrhosis & ACLF, and develop personalised treatment strategies. Discover the project!
-
Journal of Hepatology | VOL. 82
--
01 Feb 2025
Hyodeoxycholic acid ameliorates cholestatic liver fibrosis by facilitating m6A-regulated expression of a novel anti-fibrotic target ETV4
Xiaoyong Xue ... Xiaojiaoyang Li
Journal of Hepatology | VOL. -
Xiaoyong Xue, et. al.Xiaoyong Xue ... Xiaojiaoyang Li
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.